Orion
Tracked across 5 events · 32 articles · First seen May 21, 2026 · Last active Jul 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Orion is the issuer of the shares whose ownership threshold was crossed by BlackRock, Inc. The event details changes in BlackRock, Inc.'s stake in Orion.
Jun 01, 2026 · 6 articles
Tech
Impact: Orion announced positive initial Phase 1 results for its investigational drug ODM-212, which could lead to further development and potential market success in oncology.
May 21, 2026 · 6 articles
Business
Impact: Orion gains exclusive rights to distribute, market, and sell Shilpa Medicare — Shilpa Biologicals Private Limited's nivolumab biosimilar in Europe, expanding its operations in the hospital segment and strengthening its strategy to provide affordable quality medicines.
Jun 30, 2026 · 6 articles
Tech
Impact: Orion is mentioned as a third-party partner that Tenax Therapeutics relies on, indicating a potential manufacturing or development relationship.
Jul 02, 2026 · 6 articles
Business
Impact: Orion is mentioned as a company where Bird previously worked, but is not directly affected by this event.
Jul 14, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Orion live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard